A novel MPTP primate model of Parkinson's disease: Neurochemical and clinical changes

被引：32
|
作者：
Eberling, JL
Jagust, WJ
Taylor, S
Bringas, J
Pivirotto, P
VanBrocklin, HF
Bankiewicz, KS
机构：
[1] Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Funct Imaging, Berkeley, CA 94720 USA
[2] Martinez VA Med Ctr, Dept Neurol, Davis, CA USA
[3] Univ Calif Davis, Davis, CA USA
[4] CroMedica, Orinda, CA USA
来源：
BRAIN RESEARCH | 1998年 / 805卷 / 1-2期
关键词：
Parkinson's disease; MPTP; monkey; PET; dopamine; FMT;
D O I：
10.1016/S0006-8993(98)00710-0
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Positron emission tomography (PET) and the dopamine (DA) metabolism tracer, [F-18]6-fluoro-L-m-tyrosine (FMT) were used to evaluate the relationship between DA metabolism and the clinical stage of parkinsonism monkeys following either unilateral ICA MPTP infusion or unilateral ICA MPTP infusion and subsequent varying sequential systemic doses of MPTP. Clinical stage corresponded to PET measures of striatal DA metabolism, showing the usefulness of the overlesioned hemiparkinsonian monkey as a stable model of various stages of Parkinson's disease (PD). (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码：259 / 262
页数：4
相关论文
共 50 条
  • [1] Neurochemical findings in the MPTP model of Parkinson's disease
    Schmidt, N
    Ferger, B
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (11) : 1263 - 1282
  • [2] Neurochemical findings in the MPTP model of Parkinson's disease
    N. Schmidt
    B. Ferger
    [J]. Journal of Neural Transmission, 2001, 108 : 1263 - 1282
  • [3] Pathophysiology of Parkinson's disease: The MPTP primate model of the human disorder
    Wichmann, T
    DeLong, MR
    [J]. PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON, 2003, 991 : 199 - 213
  • [4] A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease
    Geldenhuys, Werner J.
    Guseman, Tamara L.
    Pienaar, Ilse S.
    Dluzen, Dean E.
    Young, Jesse W.
    [J]. PEERJ, 2015, 3
  • [5] Neurochemical and behavioural effects of acute administration of pioglitazone in the MPTP model of Parkinson's disease
    Barbiero, J.
    Moraes, L.
    Lima, M.
    Andreatini, R.
    Santiago, R.
    Vital, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S256 - S256
  • [6] The MPTP model of Parkinson's disease
    Smeyne, RJ
    Jackson-Lewis, V
    [J]. MOLECULAR BRAIN RESEARCH, 2005, 134 (01): : 57 - 66
  • [7] Excessive daytime sleepiness in the MPTP non human primate model of Parkinson's disease
    Barrand, Q.
    Lambrecq, V.
    McGuire, S.
    Hill, M.
    Tison, F.
    Bezard, E.
    Ghorayeb, I.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S433 - S433
  • [8] An Investigation on the Clinical Features and Neurochemical Changes in Parkinson's Disease With Depression
    Lian, Teng-Hong
    Guo, Peng
    Zuo, Li-Jun
    Hu, Yang
    Yu, Shu-Yang
    Liu, Li
    Jin, Zhao
    Yu, Qiu-Jin
    Wang, Rui-Dan
    Li, Li-Xia
    Piao, Ying-Shan
    Zhang, Wei
    [J]. FRONTIERS IN PSYCHIATRY, 2019, 9
  • [9] Metabolic changes associated with slow dopaminergic depletion: A longitudinal PET study in the MPTP primate model of Parkinson's disease
    Hernandez, L. F.
    Molinet-Dronda, F.
    Blesa, J.
    Juri, C.
    Collantes, M.
    Iglesias, E.
    Penuelas, I.
    Obeso, J. A.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S381 - S381
  • [10] Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model
    Barraud, Quentin
    Lambrecq, Virginie
    Forni, Claude
    McGuire, Steve
    Hill, Michael
    Bioulac, Bernard
    Balzamo, Emmanuel
    Bezard, Erwan
    Tison, Francois
    Ghorayeb, Imad
    [J]. EXPERIMENTAL NEUROLOGY, 2009, 219 (02) : 574 - 582
12345